4.4 Review

New plays in the p53 theater

期刊

出版社

CURRENT BIOLOGY LTD
DOI: 10.1016/j.gde.2010.10.002

关键词

-

资金

  1. National Cancer Institute [R37 CA40099]
  2. Flight Attendant Medical Research Institute
  3. European Commission [201102, 223151]
  4. Robert Bosch Foundation
  5. M.D. Moross Cancer Institute

向作者/读者索取更多资源

The p53 tumor suppressor and its paralogs p63 and p73 are at the crux of a network modulating cellular responses against potentially tumorigenic events. p53 acts primarily as a transcription factor, regulating the expression of both coding and non-coding RNAs, as well as the activity of RNA processing complexes. In line with their anti-tumorigenic function, p53 and p63 have recently been implicated in restricting tumor cell invasion. In parallel, a growing number of non-canonical target genes have been added to the p53 repertoire. These include genes encoding for proteins that impinge on a broad spectrum of cellular functions, from cell metabolism to stem cell renewal. The p53 story is still far from being fully told.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据